Meshima (Phellinus linteus) Anti-Angiogenesis & VEGF Inhibition
Explore mushroom research and guides on meshima (phellinus linteus) anti-angiogenesis & vegf inhibition.
How Meshima Starves Tumors: Angiogenesis Research
Meshima inhibits tumor angiogenesis at two points: VEGF production (via AKT) and the VEGF receptor (VEGFR-2). Colon, breast, and lung cancer models reviewed.
Meshima Anti-Angiogenesis: Cutting Off Tumor Blood Supply
Meshima inhibits tumor angiogenesis through three mechanisms: AKT-VEGF suppression, VEGFR-2 phosphorylation blocking, and Wnt signaling in colon models.
Meshima and VEGF Suppression: Cutting Off Tumor Blood Supply
Phellinus linteus reduces VEGF secretion via AKT inhibition upstream and blocks VEGFR-2 directly downstream. Both effects observed in preclinical research.
Meshima vs. Bevacizumab: Angiogenesis Inhibition Compared
Meshima and bevacizumab both block VEGF pathways, but through different mechanisms and at very different evidence levels. Here's the mechanistic comparison.